Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC

Clinical trial NCT04541251 · UNKNOWN

Trial details

NCT number: NCT04541251
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-small Cell Artificial Intelligence

Start date: 2020-08-01
Primary completion: 2022-07-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.